Somatostatin analogs affect proliferation of human thyroid carcinoma cell lines in vitro

Immunology and Microbiology

• Cells 100%
• Thyroid Carcinoma Cell Line 100%
• Cell Line 60%
• Growth 60%
• Membrane 60%
• Dose 60%
• Drug Megadose 40%
• Ligand Binding 40%
• Cell Count 40%
• Growth Inhibition 40%
• Thyroid 40%
• Regulatory Mechanism 20%
• Dose Response 20%
• Low Drug Dose 20%
• Carcinoma Cell 20%
• Antiproliferative Activity 20%
• Thyroid Cell Line 20%
• Binding Site 20%
• Epidermal Growth Factor 20%
• Iodine-125 20%
• Dissociation Constant 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Thyroid Carcinoma 100%
• Somatostatin Derivative 100%
• Octreotide 100%
• Ligand 66%
• Iodine-125 33%
• Somatostatin 33%
• Receptor 33%
• Membrane Protein 33%
• Binding Site 33%
• Receptor Subtype 33%
• Carcinoma 33%
• Epidermal Growth Factor 33%
• Adenoma 33%
• Electron Affinity 33%